OOIR: Observatory of International Research

Papers

(The median citation count of International Journal of Laboratory Hematology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Thrombin generation abnormalities in commonly encountered platelet function disorders	67
A multicenter evaluation of the Technoscreen ADAMTS13 activity semi‐quantitative screening test for thrombotic thrombocytopenic purpura diagnosis and exclusion	48
Biomarker diversity in increased inflammation: Secondary hemophagocytic syndrome vs. systemic inflammatory response syndrome	38
False positive Hb Bart's immunochromatographic strip test for alpha thalassaemia in delta‐beta thalassaemia carriers	37
False positive lupus anticoagulant tests in patients with high C‐reactive protein: A comparison of two hexagonal phase reagents	33
Clinical and genetic characterization of a protein S deficient patient with multiple thrombotic events	31
Thrombin generation assay in platelet‐poor plasma in children with iron deficiency anemia	28
Acute myeloid leukaemia (AML) with KMT2A rearrangement presented with haemophagocytic lymphohistiocytosis (HLH)	27
Evaluation of a diagnostic platelet aggregation test strategy for platelet rich plasma samples with low platelet counts	27
	26
A hungry Histiocyte, altered immunity and myriad of problems: Diagnostic challenges for Pediatric HLH	25
Interpretation of clot‐based lupus anticoagulant assays—Normalizing clotting time against different denominators	24
Applying index of circulating anticoagulant to mixing tests with lupus anticoagulant screen and confirm reagents can distinguish with high specificity between lupus anticoagulants and direct factor Xa	23
Influence of Anticoagulants on Platelet Counts: A Study and Recommendations From the French Speaking Cellular Hematology Group (GFHC)	22
Automated measurement of coagulation and fibrinolytic activation markers: Outcomes in coronavirus disease 2019 (COVID‐19) patients	22
The effect of oscillation depolymerization on ethylenediaminetetraacetic acid‐dependent platelet aggregation samples: A cross‐over study	21
Reference intervals of white blood cell parameters for healthy adults in japan	21
Concurrent novel RGS17::BCL9 fusion and basophilia in T/B mixed phenotype acute lymphoblastic leukemia/lymphoma	21
Molecular analysis of severe hemophilia B in Indian families: Identification of mutational hotspot and novel variants	21
Prognostic significance of bone marrow fibrosis in diffuse large B‐cell lymphoma	19
Whole blood clotting time: Current practices among Thailand National External Quality Assessment Scheme for blood coagulation member laboratories	18
Erythrophagocytosis by dysplastic neutrophils and their precursors	17
Issue Information Covers	16
Identifying a malignant B‐cell lymphoma clone in peripheral blood using immunoglobulin high‐throughput sequencing and lineage tree analysis	16
Developments in the International Journal of Laboratory Hematology	16

“Smart” WPC reflex testing enables optimal use of the WPC channel in the detection of malignant blood samples using Sysmex XN‐9100	15
Expression and prognostic relevance of long noncoding RNAs CRNDE and AOX2P in adult acute myeloid leukemia	14
Osmotic gradient ektacytometry: A tool for more than just hereditary haemolytic anaemia	14
Detection of unstable haemoglobin variants with Sysmex XN‐10	13
Emergence of a BCR::ABL1 rearrangement following a uniquely complex clonal evolution pattern in a patient undergoing Fms‐like tyrosine kinase 3 inhibitor therapy for acute myeloid leukemia	13
Invariant finding of non‐clonal bone marrow lymphocytosis, with increased B cell component, in indolent systemic mastocytosis	12
Detection of normal B cell precursors in lymph nodes samples	12
	12
Droplet digital polymerase chain reaction improves the detection of BCR‐ABL1 kinase domain mutation in Philadelphia chromosome‐positive acute lymphoblastic leukemia	12
Neutrophil and eosinophil extracellular traps in intensive care unit Covid patients' peripheral smears	12
Erythroblasts, really?	12
Blood smear and fluorescence based platelet count are key in a case of cryoglobulin masked thrombocytopenia	11
Fortuitous discovery of an NPM1 mutation in a myelodysplastic syndrome	11
Hemophagocytosis arising during disease progression of chronic myelomonocytic leukemia	11
Predictive impact of residual disease detected using multiparametric flow cytometry on risk stratification of paediatric acute myeloid leukaemia with normal karyotype	11
In vitro unexpected effects of polyphosphates observed through activated partial thromboplastin time‐based clot waveform analysis	11
Issue Information Covers	10
Incidental but rapidly progressing T‐cell prolymphocytic leukemia with t(X;14)(q28;q11) involving parotid lymphoepithelial cysts: A diagnostic pitfall	10
	10
Co‐existence of multiple myeloma and perivascular endothelial cell tumor	10
	10
Recombination frequencies of human leukocyte antigen loci in hematological malignancies among Turkish population	10
Effect of prothrombin Belgrade mutation, causing antithrombin resistance, on fibrin clot properties	9
Issue Information ‐ TOC	9
Detection of Southern Asian Ovalocytosis with Sysmex XN‐10: A complement to the decision tree previously described	9
Role of immunohistochemistry and flow cytometry in minimal residual disease detection in NPM1‐mutated AML	9
Megakaryocytic emperipolesis in a therapy‐related acute‐mixed phenotypic leukemia	9
Concurrent carcinocythemia, pleural and pericardial involvement in metastatic clear cell sarcoma	9
Reducing cytogenetic testing in the era of next generation sequencing: Are we choosing wisely?	9
Interchangeability of multiple Sysmex XN10 and XN20 modules for six types of leukocytes	9
HDAC3 single‐nucleotide polymorphism rs2530223 is associated with increased susceptibility and severity of primary immune thrombocytopenia	8
Circulating Hodgkin cells: Extending the spectrum of atypical lymphocytes	8
Early prediction of neutrophil engraftment using manual leukocyte differential count after cord blood transplantation	8
Potential of point of care tests for newborn screening for sickle cell disease: Evaluation of HemotypeSC™ and sickle SCAN® in Tanzania	8
Italian Cytometry Society (GIC) endorsement of consensus recommendations for measurable residual disease in chronic lymphocytic leukemia	8
Look beyond the plasma cells in immunocompromised patients	8
Thrombolysis in the recovery of coagulated bone marrow aspirate samples	8
Plasma cell leukemia mimicking erstwhile hairy cell leukemia variant: A case with an intriguing immunophenotype	8
Utility of Thromboelastography and velocity curve derivative in diagnosing COVID‐19 associated coagulopathy	8
Effect of tissue factor pathway inhibitor on thrombin generation assay	8
Exploiting adaptive immune receptor recombination read recoveries from exome files to identify subsets of ALL and to establish TCR features that correlate with better outcomes	8
Various approaches for accessing the influence of human leukocyte antigens disparity in haploidentical stem cell transplantation	8
Effects of CD34⁺ cell dose on haematopoietic recovery in acute lymphoblastic leukaemia patients with positive pretransplant measurable residual disease	8
Measurement of immature platelet fraction is useful in the differential diagnosis of MYH9 disorders	8
Verification of a new semi‐automated Von Willebrand factor multimers assay	8
The role of cystatin C in multiple myeloma	7
	7
Serious consequences of Epstein‐Barr virus infection: Hemophagocytic lymphohistocytosis	7
Flow cytometric analysis of platelet function to detect high on‐treatment residual platelet reactivity in patients on dual antiplatelet therapy	7
Biologic characterization of atypical chronic lymphocytic leukaemia	7

A novel SPTB frameshift deletion causing hereditary spherocytosis identified by next‐generation sequencing in a Chinese family	7
Validation of a single tube 3‐colour immature red blood cell screening assay for the detection and enumeration of small, medium and large paroxysmal nocturnal haemoglobinuria clones by flow cytometry	7
The effect of erythrocyte lysing reagents on enumeration of leukocyte subpopulations compared with a no‐lyse‐no‐wash protocol	7
Accuracy study of a novel alternate method measuring erythrocyte sedimentation rate for prototype hematology analyzer Celltac α+	7
Clinical and pathologic challenges of clonal cytopenia of undetermined significance	7
The evaluation of overall hemostatic potential assay in patients with COVID‐19 infection	7
Anaemia can be improved by controlling the disease activity of Takayasu's arteritis without iron administration	7
Artifactual prolongation of the activated partial thromboplastin time by amikacin or gentamicin with ellagic acid, but not silica activated reagent	7
Molecular diagnosis of hereditary hemolytic anemias: Recent updates	6
	6
Marked polytypic proliferation of immunoblasts, plasmacytoid lymphocytes, and plasma cells in bronchoalveolar lavage fluid in SARS‐CoV‐2 infection	6
Early hematological indicators of severe COVID‐19 disease in hospitalized patients: Data from a South Asian population	6
T‐lymphoblastic leukaemia/lymphoma with Burkitt‐like morphology	6
	6
Comparison of platelet count results on the Sysmex XN between citrate or MgSO₄ and K2 EDTA anticoagulants	6
Full spectral flow cytometry analysis of the bone marrow immune cells in patients with myelodysplastic syndrome	6
Complete blood count and cell population data parameters from the Abbott Alinity hq analyzer are useful in differentiating myelodysplastic syndromes from other forms of cytopenia	6
Issue Information Covers	6
T‐prolymphocytic leukaemia with sezary‐like morphology	6
Issue Information Covers	6
2022 update on the major activities of the International Society for Laboratory Hematology	6
Study of in vitro thrombin generation after neutralization of heparin	6
Recent developments in the International Journal of Laboratory Hematology	6
Evaluation of Sigma metric approach for monitoring the performance of automated analyzers in hematology unit of Alexandria Main University Hospital	6
Is monitoring of antiplatelet therapy by light transmission aggregometry dependent on instrument and reagent used?	6
Early T‐cell precursor acute lymphoblastic leukemia with Auer rods in mature granulocytes	6
Retracted: White blood cell differentials performance of a new automated digital cell morphology analyzer: Mindray MC‐80	6
Disseminated Talaromyces marneffei in peritoneal fluid of a patient with HIV	6
Acute granular lymphoblastic leukemia with prominent nucleoli and large cytoplasmic granules	6
Neutrophils with bright green inclusions in a patient with chest pain	6
Acute basophilic leukemia in a patient with down syndrome: A case report and review of literature	6
International society for laboratory hematology: Focus on education	6
LncRNA CRNDE is downregulated and associated with poor prognostic markers in chronic lymphocytic leukemia	6
Sex‐associated differences in genomic profile of chronic myelomonocytic leukemia involving differential representation of SRSF2 gene mutation	6
Assessment of Hemoglobin A2 stability at room temperature during 24 or 25 days as measured by high pressure liquid chromatography and capillary electrophoresis	6
Characteristic vacuolization of myeloid precursors and UBA1 mutation in a woman with monosomy X	6
Hemophagocytic histiocytosis in severe SARS‐CoV‐2 infection: A bone marrow study	6
Alpha Thalassemia Screening in Multiethnic Population in Northern Europe Using Hb Bart's Immunochromatographic Test	6
A lineage switch from NPM1‐mutant acute myeloid leukemia to acute T‐cell lymphoblastic leukemia with KMT2D and ARID2 mutant	5
Effect of DOAC‐Remove on coagulation screening assays in samples from patients receiving oral or parenteral anticoagulation	5
Isolated erythrocytosis: A consequence of COVID‐19 induced hypoxia	5
Carcinocythemia in metastatic breast cancer detected by high fluorescent signals on an automated Sysmex XN‐9100 hematological cell counter	5
High plateletcrit may be associated with thrombotic risk in polycythemia vera	5
Absolute Immature Platelet Count: An Accessible Biomarker to Distinguish Aplastic Anemia and Immune Thrombocytopenia	5
A case of neutrophil blue–green inclusions in severe fever with thrombocytopenia syndrome virus infection	5
Lymphocytes screening on admission is essential for predicting in‐hospital clinical outcome in COVID‐19 patients: A retrospective cohort study	5
Performance comparison of Westergren modified SRS 100/II and alternate iSED® method for erythrocyte sedimentation rate	5
Lineage switch from acute myeloid leukemia with KMT2A‐PTD to mixed phenotype acute leukemia with t(v;11q23)	5
A case of azathioprine‐induced aplastic anemia	5
A rare case of bone marrow infiltration by Langerhans cell with bilobed and folded lobulated nuclei	5
Acute Megakaryocytic Leukemia arising from Megakaryocyte/Erythroid Progenitor (MEP)‐like cell	5
Systematic application of fluorescence in situ hybridization and immunophenotype profile for the identification of ZNF384 gene rearrangements in B cell acute lymphoblastic leukemia	5
Reference interval of antithrombin, protein C, and protein S activities in healthy adults in Iran, the effect of age, sex, oral contraceptive intake, and menopause	5
Defining ferritin clinical decision limits to improve diagnosis and treatment of iron deficiency: A modified Delphi study	5
Flow cytometric myeloma measurable residual disease testing in the era of targeted therapies	5
The mismatch between Sysmex XN‐20 automated hematology analyzers and the visual examination of blood smears—Misclassification of hypogranular eosinophils and platelets	5
P‐Loop mutations—Negative prognosticators in tyrosine kinase inhibitors resistant chronic myeloid leukemia patients	5
Diagnosing heparin‐induced thrombocytopenia: The need for accuracy and speed	5
Peripheral granular lymphocytopenia and dysmorphic leukocytosis as simple prognostic markers in COVID‐19	5
The hemoglobinopathies, molecular disease mechanisms and diagnostics	5
Interference of D‐dimer levels from heterophilic antibody in COVID‐19: A serious concern in treatment and follow‐up of patients	5
Blue‐green cytoplasmic inclusions in neutrophils/monocytes of patients with yellow fever	5
Pseudoeosinophilia and pseudothrombocytopenia due to neutrophils phagocytosis of platelets in peripheral blood	5
Validation of a novel algorithm with a high specificity in ruling out MDS	4
Flow Cytometric Intracellular 5‐Methyl Cytosine Expression and Its Correlation With Cytogenetics and Measurable Residual Disease in Adult B‐Lineage Acute Lymphoblastic Leukemia	4
Identification of a novel and rare α⁰‐thalassemia 27.0 kb deletion with 9 bp insertion (Lamphun deletion; ‐‐^LAMPHUN) in a Thai family	4
Spurious Lymphocyte Differential Counts: An Unusual Cytomorphometric Interference of Target Cells—A Tale of Two Automated Hematology Analyzers	4
Brief communication: Heparin‐calibrated chromogenic anti‐Xa assay for the detection of threshold‐levels of direct oral anticoagulants	4
Evaluation of the WBC‐differential flagging performances and accuracy of the HORIBA Yumizen H2500 cell counter in oncology patients from a single institution	4
DOAC‐Remove to counteract the interference of anti‐Xa oral anticoagulants on the monitoring of heparin	4
Neonatal diagnosis of congenital dyserythropoietic anemia type II	4
Overview on Hereditary Spherocytosis Diagnosis	4
Mature plasmacytoid dendritic cell proliferation associated with acute myeloid leukemia	4
Definition of Significant Platelet Clumping: Should We Review All Samples With a Platelet Clumping Flag From Automated Hematology Analyzer?	4
Overt primary myelofibrosis with coexistence of JAK2V617F and MPLW515R driver mutations	4
The structural parameters and flags of the Sysmex XN™ analyser: Are they discriminative between reactive and malignant lymphocytosis in the context of lymphocyte counts above 5 × 10⁹/L in a	4
An Unusual Presentation of EATL	4
Plasmablastic lymphoma: An update	4
Clinical utility of Abbott Alinity hq extended red blood cell parameters in differentiating β‐thalassemia trait and iron deficiency anemia	4
Evaluation of an integrated activated partial thromboplastin time (Cephen LS/Cephen) for the detection of lupus anticoagulant	4

An automated method for thrombocyte counting in capillary microsamples	4
Differences between capillary and venous blood counts in children—A data mining approach	4
Utility of CD229 as novel marker in measurable residual disease assessment in multiple myeloma—An evidence‐based approach	4
Clinicopathologic and Molecular Characterization of NUP98‐Rearranged Acute Leukemias	4
Frozen/Thawed Samples Can Replace Fresh Samples for Assignment of ISI to Secondary Thromboplastin Standards for Multiple Reagent/Instrument Combinations: Data to Support Possible Revision o	4
	4
Mitigating Lipemia Interference in Anti‐Xa Activity Measurement Through High‐Speed Centrifugation	4
Vivax malaria detection using a parasitic red blood cell flag generated by the Sysmex XN‐9000 hematology analyzer	4
Digital morphology compared to the optical microscope: A validation study on reporting bone marrow aspirates	4
Diagnostic Implications of CD63 and CD64 Expression Levels and FcγRIIIA 158 V/F Gene Polymorphism in Primary Immune Thrombocytopenia Adult Patients	4
Measurement of antifactor VIII antibody titre in the presence of emicizumab; Use of chromogenic Bethesda assays	4
	4
A case report of a Chediak‐Higashi syndrome diagnosed by peripheral blood smear	4
Laboratory testing for suspected COVID‐19 vaccine–induced (immune) thrombotic thrombocytopenia	4
Methods, precision, and analytical sensitivity of a novel low‐plasma‐volume assay of fibrinolytic capacity utilizing the euglobulin fraction	4
Does in vitro hemolysis affect measurements of plasma apixaban concentration by UPLC‐MS and anti‐Xa assay?	4
Unicentric Castleman Disease: Updates and Novel Insights Into Spindle Cell Proliferations and Aggressive Forms of a Localized Disease	4
Intracellular Brucella melitensis in the cerebrospinal fluid and peripheral blood	4
Post‐Induction Bone Marrow Necrosis With Carbapenem‐Resistant Enterobacteriaceae in a Case of B‐Acute Lymphoblastic Leukemia	4
	4
Monocyte distribution width as a screening tool for COVID‐19: A systematic review and meta‐analysis	3
Investigation of mutations in Fanconi anemia genes and malignancy predisposition in Brazilian patients	3
Post‐hospitalization venous thromboembolism in COVID‐19 patients: Evidence against routine post‐hospitalization prophylactic anticoagulation	3
Discrepancy between recipient and donor rs4364254 heparanase single nucleotide polymorphism impacts graft‐versus‐host disease after allogeneic stem cell transplant	3
Issue Information Covers	3
Mindray BC‐6800 haematological analyser: 3D‐DIFF scattergram usefulness in infectious mononucleosis diagnosis	3
Serum calprotectin (S100A8/A9) levels as a new potential biomarker of treatment response in Hodgkin lymphoma	3
Red cell distribution width and in‐hospital mortality in septic shock: A public database research	3
Discordant high‐grade B‐cell lymphoma with MYC and BCL6 rearrangements presenting as a pericardial effusion	3
Machine learning models outperform manual result review for the identification of wrong blood in tube errors in complete blood count results	3
Comparison of the performance of two automatic cell morphology analyzers for peripheral‐blood leukocyte morphology analysis: Mindray MC‐100i and Sysmex DI‐60	3
Extramedullary myelodysplastic/myeloproliferative neoplasm (MDS/MPN) with ring sideroblasts and thrombocytosis	3
Stability and comparison of complete blood count parameters between capillary and venous blood samples	3
Circ_0009910 sponges miR‐491‐5p to promote acute myeloid leukemia progression through modulating B4GALT5 expression and PI3K/AKT signaling pathway	3
Comparative analysis of automated cell counts in oncological patients: Reliable results of point of care blood impedance measurements and pitfalls in myelodysplastic neoplasias and acute myeloid	3
International council for standardisation in haematology recommendations on fibrinogen assays, thrombin clotting time and related tests in the investigation of bleeding disorders	3
Reducing our carbon footprint in the haematology laboratory: A shared responsibility	3
Definite diagnosis of plasma prekallikrein deficiency should not be based exclusively on shortening of the aPTT upon prolonged pre‐incubation	3
Crystal‐storing histiocytosis associated with monoclonal kappa light chain gammopathy	3
Establishment and verification of review criteria for blood cell analysis in children	3
The value of bone marrow examinations performed in the investigation of HIV infected patients with cytopenias	3
Inactive T‐cell prolymphocytic leukemia with negative surface CD3: Cytogenetic pitfalls	3
A high level of Hb F unmasks a new case of Hb Wanjiang (β (F3‐F4) Ala87_Thr88delinsSer_Gln (HBB:c.255_264 delinsTTTTTCTCAG)) in a pregnant woman of African ancestry	3
Arterial blood as an alternative specimen source for complete blood cell count: More human studies are needed	3
A career in solving clinical‐pathological conundrums: Heyde syndrome, anti‐platelet factor 4 disorders, and microvascular limb ischemic necrosis	3
Molecular characterization and prognosis of mutant TP53 acute myeloid leukemia and myelodysplastic syndrome with excess blasts	3
Leucoagglutination resolved by warming to 37°C	3
Persisting with persistent thrombocytosis	3
Role of flow cytometry in evaluation of the cellular therapy products used in haematopoietic stem cell transplantation	3
Effects of circadian variation, lifestyle and environment on hematological parameters: A narrative review	3
Impact of COVID‐19 pandemic on the quality of test output in haemostasis laboratories	3
Analytical validation of white blood cell differential and platelet assessment on the Sysmex DI‐60 digital morphology analyzer	3
Issue Information ‐ TOC	3
Interpreting sulfhemoglobin and methemoglobin in patients with cyanosis: An overview of patients with M‐hemoglobin variants	3
Testing for rare types of Hereditary Hemochromatosis. A genetic study of two Italian families affected by early onset iron overload	3
Issue Information ‐ TOC	3
Chronic neutrophilic leukemia associated with thrombocytosis and a CSF3R Q781* nonsense mutation	3
The International Council for Standardization in Haematology: 60 years (1963–2023)	3
Pre‐analytical variables in haemostasis: Findings from the United Kingdom National External Quality Assessment scheme for Blood Coagulation (UK NEQAS BC) haemolysis exercise	3
	3
Increased CD23 expression in postsplenectomy polyclonal B‐Cell lymphocytosis	3
Impact of aPTT reagents on measurement of a PEGylated recombinant FVIII (Adynovi^®/Adynovate^®): A French multicentric field assay study	3
Recurrent RARG trinary fusion and ligand binding domain truncation in variant acute promyelocytic leukemia resistant to retinoic acid but sensitive to homoharringtonine‐based therapy	3
Viscoelastic testing: Critical appraisal of new methodologies and current literature	3
A simplified diagnostic pathway for the differential diagnosis of iron deficiency anaemia and anaemia of chronic disease	3
Abstracts	3
Reflex factor coagulation testing in patients with an unexplained prolonged aPTT: An institutional retrospective review	3
A multi‐laboratory assessment of lupus anticoagulant assays performed on the ACL TOP 50 family for harmonized testing in a large laboratory network	3
Diagnostic insights from chemometric analysis of hemogram inflammatory indexes in male smokers with and without asthma or chronic obstructive pulmonary disease	3
Neutrophil‐to‐lymphocyte ratio and platelet‐to‐lymphocyte ratio as new possible minor criteria for diagnosis of polycythemia vera	3
The role of molecular diagnostic testing for hemoglobinopathies and thalassemias	3
Evaluation of two fully automated ADAMTS13 activity assays in comparison to manual FRET assay	3
Optimizing the management of analytical interferences affecting red blood cells on XN‐10 (Sysmex®)	3
The new way to identify Leishmania amastigotes in peripheral blood smear using digital cell morphology instrument	3
A familial case of basophilic stippling cells in lead poisoning	3
Profiling endogenous, environmental, and infectious disease mutational signatures in blastic plasmacytoid dendritic cell neoplasms	3
	3
Additional mutations in IDH1/2‐mutated patients with acute myeloid leukemia	3
FLT‐3 mutation maybe an inferior predictor of daratumumab therapy in acute myeloid leukemia patients relapsed after allogeneic stem cell transplantation	3
In special coagulation, think horses not zebras: A clotted sample from a patient with congenital disorder of glycosylation	3
Guidance for establishing a factor VIII testing protocol for the myriad of factor VIII products	2
Adult mixed phenotype acute leukemia (MPAL): B/myeloid MPAL^isoMPO is distinct from other MPAL subtypes	2
High‐purity isolation platelets by gradient centrifugation plus filtration	2
An audit of disseminated intravascular coagulation screen requests at an academic hospital laboratory in central South Africa	2
Quantification and optimization of clot retraction in washed human platelets by Sonoclot coagulation analysis	2
White blood cell differentials performance of a new automated digital cell morphology analyzer: Mindray MC‐80	2
Cell Population Data NE‐WX, NE‐FSC, LY‐Y of Sysmex XN‐9000 can provide additional information to differentiate macrocytic anaemia from myelodysplastic syndrome: A preliminary study	2
Breakpoint characterization of a rare alpha⁰‐thalassemia deletion using targeted locus amplification on genomic DNA	2
Morphology of myeloproliferative neoplasms	2
To B‐ or not to B‐: A review of lineage switched acute leukemia	2
UK NEQAS Haematology pilot scheme: Reticulocyte haemoglobin content quantitation	2
Change in platelet indices in patients with Coronavirus disease‐2019 (COVID‐19): A reflection of platelet activation and contribution to immunothrombosis?	2
Pediatric reference intervals for hematology parameters in healthy infants and young children in Iran	2
A case of a primary myelofibrosis with progression and related literature review of progression phase genetics	2
Prognostic gene expression analysis in a retrospective, multinational cohort of 155 multiple myeloma patients treated outside clinical trials	2